Search
Find a recruiting study
7,114 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 28, 2026). No sign-up needed.
Most recently updated studies · page 90 of 297
- RecruitingPhase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
AstraZeneca
- Location
- Minneapolis, MN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
AbbVie
- Location
- Glendale, AZ + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Novo Nordisk A/S
- Location
- Birmingham, AL + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
GlaxoSmithKline
- Location
- Doral, FL + 1 other US site
- Eligibility basics
- Ages 40–80
- Recruiting
Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer
Kevin Doody
- Location
- Bedford, TX
- Eligibility basics
- Ages 18–35 · Women only
- Recruiting
Pedal Pump Clinical Trial on Edema V2
Hillcrest
- Location
- Tulsa, OK
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Birmingham, AL + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2/Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline
- Location
- Scottsdale, AZ + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GlaxoSmithKline
- Location
- Los Angeles, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Ipsen
- Location
- Fountain Valley, CA + 6 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Pivotal Study of N-acetyl-L-leucine for CACNA1A
IntraBio Inc
- Location
- Baltimore, MD + 2 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 2
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
H. Lundbeck A/S
- Location
- Farmington Hills, MI + 1 other US site
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1/Phase 2
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Ferring Pharmaceuticals
- Location
- Mobile, AL + 3 other US sites
- Eligibility basics
- Ages 1–8
- RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice…
Eli Lilly and Company
- Location
- Phoenix, AZ + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Turn Therapeutics
- Location
- Irving, TX
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Axsome Therapeutics, Inc.
- Location
- Glendale, AZ + 48 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
ADARx Pharmaceuticals, Inc.
- Location
- Las Vegas, NV + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Eli Lilly and Company
- Location
- Phoenix, AZ + 31 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Eli Lilly and Company
- Location
- Birmingham, AL + 35 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Novo Nordisk A/S
- Location
- Conyers, GA + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
Voyager Therapeutics
- Location
- Maitland, FL
- Eligibility basics
- Ages 30–80
- RecruitingPhase 3
Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)
Regenerative Ocular Immunobiologics LLC
- Location
- Beverly Hills, CA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Astellas Institute for Regenerative Medicine
- Location
- Los Angeles, CA + 12 other US sites
- Eligibility basics
- Ages 50+
Data source: daily sync of the ClinicalTrials.gov API. How we list studies